Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TNP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | NBPF20 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | NUGGC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | DYRK1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ZKSCAN4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ZMYM4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | RER1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PLA2G6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PHLPP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |